Nuveen Asset Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 97,318 shares of ARCT stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

97,318

Previous 89,643 8.56%

Holding current value

$1.7 Million

Previous $2.18 Million 3.48%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$18.08 - $25.38 $138,764 - $194,791	7,675 Added 8.56%	97,318 $2.26 Million
Q2 2024 Aug 09, 2024	SELL	$24.35 - $44.39 $833,305 - $1.52 Million	-34,222 Reduced 27.63%	89,643 $2.18 Million
Q1 2024 May 13, 2024	SELL	$31.23 - $42.99 $2.21 Million - $3.04 Million	-70,817 Reduced 36.38%	123,865 $4.18 Million
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $5,950 - $11,077	336 Added 0.17%	194,682 $6.14 Million
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $152,996 - $224,622	6,014 Added 3.19%	194,346 $4.97 Million
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $961,621 - $1.3 Million	40,168 Added 27.11%	188,332 $5.4 Million
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $1.17 Million - $1.91 Million	79,617 Added 116.15%	148,164 $3.55 Million
Q4 2022 Feb 14, 2023	SELL	$14.14 - $23.06 $587,389 - $957,935	-41,541 Reduced 37.73%	68,547 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $19,340 - $32,796	1,482 Added 1.36%	110,088 $1.63 Million
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $210,234 - $534,503	17,148 Added 18.75%	108,606 $1.71 Million
Q1 2022 May 16, 2022	SELL	$17.64 - $39.57 $61,157 - $137,189	-3,467 Reduced 3.65%	91,458 $2.24 Million
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $146,786 - $204,127	4,292 Added 4.74%	94,925 $3.51 Million
Q3 2021 Nov 12, 2021	SELL	$27.88 - $58.25 $1.05 Million - $2.19 Million	-37,539 Reduced 29.29%	90,633 $4.94 Million
Q2 2021 Aug 16, 2021	BUY	$25.79 - $42.11 $1.29 Million - $2.1 Million	49,906 Added 63.76%	128,172 $4.34 Million
Q1 2021 May 17, 2021	SELL	$38.75 - $86.92 $695,446 - $1.56 Million	-17,947 Reduced 18.65%	78,266 $3.23 Million
Q4 2020 May 17, 2021	SELL	$34.61 - $123.66 $369,565 - $1.32 Million	-10,678 Reduced 9.99%	96,213 $4.17 Million
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $1.2 Million - $4.28 Million	34,614 Added 47.89%	106,891 $4.64 Million
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $365,340 - $615,786	9,745 Added 15.58%	72,277 $3.1 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $791,655 - $3.64 Million	62,532 New	62,532 $2.92 Million

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $465M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History